Fauci Says Just One Covid-19 Vaccine Won’t Be Enough
(Bloomberg) --
The world needs more than one vaccine to tackle the new coronavirus, even as pharma companies race to be the first with a pandemic shot, said U.S. infectious-disease expert Anthony Fauci.
“I'd love to see more than one vaccine get to the goal line, as it were,” Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, said in a BBC radio interview Thursday. “The world needs more than one vaccine.”
Drugmakers such as Pfizer Inc., AstraZeneca Plc, Moderna Inc. and dozens of other biopharmaceutical outfits and academic groups are vying to come up with a safe and effective vaccine against Covid-19. With almost 10.5 million confirmed cases around the globe and over half a million deaths, drugmakers are under increasing pressure to deliver.
Having multiple vaccines will be necessary not just to produce the billions of doses needed to meet demand across the globe. Some drugmakers are focused on specific needs, like making a shot that lasts longer or doesn't require stringent cold-storage supply chains. And of course there's the potential for unexpected setbacks or failure.
“You've got to be careful if you're temporarily leading the way versus having a vaccine that's actually going to work,” Fauci said when asked about one of the most advanced contenders under development from Oxford University and AstraZeneca.
Pfizer and German partner BioNtech SE released some promising results on their experimental shot Wednesday, but any optimism about development advances was doused when U.S. regulators released conditions for vaccine approval. The Food and Drug Administration said any candidate would need to prove itself at least 50% more effective than a placebo to win clearance, rather than merely showing immune-response data. That may delay the first shots to the start of next year, analysts said.
©2020 Bloomberg L.P.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
